Fecal microbiota transplant for recurrent clostridium difficile infection: Mayo clinic in Arizona experience

Neal C. Patel, Cheryl L. Griesbach, John K. DiBaise, Robert Orenstein

Research output: Contribution to journalArticle

39 Citations (Scopus)

Abstract

Objective: To report the initial experience of treating recurrent Clostridium difficile infection (CDI) with fecal microbiota transplant (FMT) at Mayo Clinic in Arizona. Patients and Methods: The study retrospectively reviewed FMTs performed at Mayo Clinic in Arizona between January 1, 2011, and January 31, 2013. All the recipients had multiple recurrent CDIs unresponsive to traditional antibiotic drug therapy. A standardized protocol was developed to identify patients, screen donors, perform FMT, and determine outcomes via telephone surveys. Results: Thirty-one patients (mean ± SD age, 61.26±19.34 years) underwent FMT. Median time from index infection to FMT was 340 days. Ninety-seven percent (29 of 30) of patients reported substantial improvement or resolution of diarrhea (median time to improvement, 3 days), 74% (17 of 23) reported improvement or resolution of abdominal pain (median time to improvement, 3 days), and 55% (16 of 29) had improvement or resolution of fatigue (median time to improvement, 6 days). Three patients underwent repeated FMT owing to persistent symptoms; 2 reported improvement in diarrhea with the second therapy. No serious adverse events directly related to FMT were reported. Conclusion: A standardized regimen of FMT for recurrent CDI is safe, is highly effective, and can be provided using a relatively simple protocol.

Original languageEnglish (US)
Pages (from-to)799-805
Number of pages7
JournalMayo Clinic Proceedings
Volume88
Issue number8
DOIs
StatePublished - 2013

Fingerprint

Clostridium Infections
Clostridium difficile
Microbiota
Diarrhea
Fecal Microbiota Transplantation
Telephone
Abdominal Pain
Fatigue
Tissue Donors
Anti-Bacterial Agents
Drug Therapy
Infection

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Fecal microbiota transplant for recurrent clostridium difficile infection : Mayo clinic in Arizona experience. / Patel, Neal C.; Griesbach, Cheryl L.; DiBaise, John K.; Orenstein, Robert.

In: Mayo Clinic Proceedings, Vol. 88, No. 8, 2013, p. 799-805.

Research output: Contribution to journalArticle

Patel, Neal C. ; Griesbach, Cheryl L. ; DiBaise, John K. ; Orenstein, Robert. / Fecal microbiota transplant for recurrent clostridium difficile infection : Mayo clinic in Arizona experience. In: Mayo Clinic Proceedings. 2013 ; Vol. 88, No. 8. pp. 799-805.
@article{a884b8840a6445248db9b46a959abb50,
title = "Fecal microbiota transplant for recurrent clostridium difficile infection: Mayo clinic in Arizona experience",
abstract = "Objective: To report the initial experience of treating recurrent Clostridium difficile infection (CDI) with fecal microbiota transplant (FMT) at Mayo Clinic in Arizona. Patients and Methods: The study retrospectively reviewed FMTs performed at Mayo Clinic in Arizona between January 1, 2011, and January 31, 2013. All the recipients had multiple recurrent CDIs unresponsive to traditional antibiotic drug therapy. A standardized protocol was developed to identify patients, screen donors, perform FMT, and determine outcomes via telephone surveys. Results: Thirty-one patients (mean ± SD age, 61.26±19.34 years) underwent FMT. Median time from index infection to FMT was 340 days. Ninety-seven percent (29 of 30) of patients reported substantial improvement or resolution of diarrhea (median time to improvement, 3 days), 74{\%} (17 of 23) reported improvement or resolution of abdominal pain (median time to improvement, 3 days), and 55{\%} (16 of 29) had improvement or resolution of fatigue (median time to improvement, 6 days). Three patients underwent repeated FMT owing to persistent symptoms; 2 reported improvement in diarrhea with the second therapy. No serious adverse events directly related to FMT were reported. Conclusion: A standardized regimen of FMT for recurrent CDI is safe, is highly effective, and can be provided using a relatively simple protocol.",
author = "Patel, {Neal C.} and Griesbach, {Cheryl L.} and DiBaise, {John K.} and Robert Orenstein",
year = "2013",
doi = "10.1016/j.mayocp.2013.04.022",
language = "English (US)",
volume = "88",
pages = "799--805",
journal = "Mayo Clinic Proceedings",
issn = "0025-6196",
publisher = "Elsevier Science",
number = "8",

}

TY - JOUR

T1 - Fecal microbiota transplant for recurrent clostridium difficile infection

T2 - Mayo clinic in Arizona experience

AU - Patel, Neal C.

AU - Griesbach, Cheryl L.

AU - DiBaise, John K.

AU - Orenstein, Robert

PY - 2013

Y1 - 2013

N2 - Objective: To report the initial experience of treating recurrent Clostridium difficile infection (CDI) with fecal microbiota transplant (FMT) at Mayo Clinic in Arizona. Patients and Methods: The study retrospectively reviewed FMTs performed at Mayo Clinic in Arizona between January 1, 2011, and January 31, 2013. All the recipients had multiple recurrent CDIs unresponsive to traditional antibiotic drug therapy. A standardized protocol was developed to identify patients, screen donors, perform FMT, and determine outcomes via telephone surveys. Results: Thirty-one patients (mean ± SD age, 61.26±19.34 years) underwent FMT. Median time from index infection to FMT was 340 days. Ninety-seven percent (29 of 30) of patients reported substantial improvement or resolution of diarrhea (median time to improvement, 3 days), 74% (17 of 23) reported improvement or resolution of abdominal pain (median time to improvement, 3 days), and 55% (16 of 29) had improvement or resolution of fatigue (median time to improvement, 6 days). Three patients underwent repeated FMT owing to persistent symptoms; 2 reported improvement in diarrhea with the second therapy. No serious adverse events directly related to FMT were reported. Conclusion: A standardized regimen of FMT for recurrent CDI is safe, is highly effective, and can be provided using a relatively simple protocol.

AB - Objective: To report the initial experience of treating recurrent Clostridium difficile infection (CDI) with fecal microbiota transplant (FMT) at Mayo Clinic in Arizona. Patients and Methods: The study retrospectively reviewed FMTs performed at Mayo Clinic in Arizona between January 1, 2011, and January 31, 2013. All the recipients had multiple recurrent CDIs unresponsive to traditional antibiotic drug therapy. A standardized protocol was developed to identify patients, screen donors, perform FMT, and determine outcomes via telephone surveys. Results: Thirty-one patients (mean ± SD age, 61.26±19.34 years) underwent FMT. Median time from index infection to FMT was 340 days. Ninety-seven percent (29 of 30) of patients reported substantial improvement or resolution of diarrhea (median time to improvement, 3 days), 74% (17 of 23) reported improvement or resolution of abdominal pain (median time to improvement, 3 days), and 55% (16 of 29) had improvement or resolution of fatigue (median time to improvement, 6 days). Three patients underwent repeated FMT owing to persistent symptoms; 2 reported improvement in diarrhea with the second therapy. No serious adverse events directly related to FMT were reported. Conclusion: A standardized regimen of FMT for recurrent CDI is safe, is highly effective, and can be provided using a relatively simple protocol.

UR - http://www.scopus.com/inward/record.url?scp=84884643861&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84884643861&partnerID=8YFLogxK

U2 - 10.1016/j.mayocp.2013.04.022

DO - 10.1016/j.mayocp.2013.04.022

M3 - Article

C2 - 23910407

AN - SCOPUS:84884643861

VL - 88

SP - 799

EP - 805

JO - Mayo Clinic Proceedings

JF - Mayo Clinic Proceedings

SN - 0025-6196

IS - 8

ER -